Glaukos (GKOS) news
Recent news
Glaucos Corporation: BTIG raises target price to $202 from $193
BTIG has raised its 12-month price target for Glaukos Corporation (NYSE:GKOS) to $202 from $193, while maintaining a "Buy" rating on the stock. This adjustment reflects the firm's continued confidence in Glaukos' product pipeline and recent financial performance. The stock currently trades at…
AInvest Wire · Aug 20, 2026Glaucos Corp: BTIG raises target price to $164 from $162
BTIG has raised its price target for Glaukos Corporation (NYSE: GKOS) to $164 from $162, while maintaining its Buy rating for the medical technology firm . The stock is currently trading at $143.82, near its 52-week high of $148.11. Glaukos has delivered a 52% return over the past year and has a…
AInvest Wire · Jul 13, 2026Glaucos Corp: H.C. Wainwright initiates coverage with buy rating; target price $168
H.C. Wainwright & Co. has initiated coverage of Glaukos Corporation (NYSE: GKOS) with a "Buy" rating and a target price of $168, reflecting the firm’s positive outlook on the company’s growth prospects and product pipeline . The stock currently trades at $127.53, implying a potential 32% upside…
AInvest Wire · Jul 6, 2026Needham raises target price to $150 from $136 for Glaukos Corp
AInvest Wire · Jun 17, 2026Citigroup raises target price to $162 from $140 for Glaukos Corp
AInvest Wire · Jun 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.